Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01590875 · ClinicalTrials.gov registry record · NA
Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01590875 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 20 participants.
The verdict
NCT01590875, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Adenosine is used clinically to assess permanency of electrical isolation of pulmonary veins during atrial fibrillation ablation, however, the methodology has not been validated either in terms of the reproducibility of the adenosine response or the effect on clinical outcomes, namely whether using pulmonary vein reconnection to guide additional ablation lowers rate recurrent atrial fibrillation post ablation. Study will test the hypothesis that the response to adenosine used in this manner is reproducible over time.
Interventions
- DRUG Adenosine arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01590875
The ClinicalTrials.gov registry entry for NCT01590875 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adenosine arm is the first listed.
NCT01590875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01590875 about?
NCT01590875 is a clinical study titled "Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation". Adenosine is used clinically to assess permanency of electrical isolation of pulmonary veins during atrial fibrillation ablation, however, the methodology has not been validated either in terms of the reproducibility of the adenosine response or the effect on clinical outcomes, namely whether using ...
What is the current status of trial NCT01590875?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01590875?
The interventions under investigation include: Adenosine arm (DRUG).
Who is sponsoring clinical trial NCT01590875?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.